Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More
Report from the legal press
Headline as published by Law360 Product Liability on Oct 27, 2026; collected by the wire Oct 27, 2026, 7:00 PM ET.
Coverage
Named in this story
- FirmLaw360Linked on a hard id: the report is published on the firm’s own domain (
law360.com
). - MDLMDL 2738 · J&J TalcMatched on
talc
- MDLMDL 3094 · GLP-1 Receptor AgonistsMatched on
GLP-1
Topics
- Mass torts and MDLsMatched on
talc
- Toxic exposureMatched on
Mesothelioma
- Wrongful deathMatched on
wrongful death
- Verdicts and settlementsMatched on
verdict
Explore the named firms, organizations and MDL dockets above. Sources and method
MDL No. 2738
J&J Talc
IN RE: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation
- Transferee judge
- Michael A. Shipp
- Court
- District of New Jersey
- Actions pending
- 69,340
Per the JPML pending-dockets report of October 1, 2026.
MDL No. 3094
GLP-1 Receptor Agonists
IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
- Transferee judge
- Karen S. Marston
- Court
- Eastern District of Pennsylvania
- Actions pending
- 4,025
Per the JPML pending-dockets report of October 1, 2026.